Delhi hospital uses Monoclonal antibody therapy on two COVID-19 patients; discharges 12 hours later
Both patients were given REGCov2, which has been developed to produce resistance against SARS-CoV-2. Both COVID-19 patients managed to recover from their ailments and were discharged within 12 hours
BusinessToday.In | June 10, 2021 | Updated 14:58 IST
Monoclonal antibodies are identical copies of an antibody that targets one specific antigen
New Delhi's Sir Ganga Ram Hospital on Thursday reported successful usage of Monoclonal antibody therapy for treating two COVID-19 patients, The patients were suffering from fast progression of symptoms within the first seven days of the disease. Both patients were given REGCov2, which has been developed to produce resistance against SARS-CoV-2. Both COVID-19 patients managed to recover from their ailments and were discharged within 12 hours.